47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
68.20.Z - Rental and management of own or leased real estate
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.99.Z - Other business support activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -68,8 | |||
Gross profit (loss) | 0,8 | 0,3 | -0,3 | -219,5 |
EBITDA | 0,9 | 0,6 | 0 | -92,8 |
Short time liabilities | 2,6 | 3,9 | 3,8 | -3 |
Other operating costs | 0 | |||
Equity capital | -0,6 | -0,3 | -0,6 | -121,2 |
Operating profit (EBIT) | 0,9 | 0,5 | 0 | -93,6 |
Assets | 4,7 | 6,8 | 7,5 | 10,9 |
Net profit (loss) | 0,8 | 0,3 | -0,3 | -219,5 |
Cash | 0,9 | 0,7 | 0,5 | -31,3 |
Net income from sale | 26,2 | 32,2 | 37,9 | 17,8 |
Liabilities and provisions for liabilities | 5,3 | 7,1 | 8,2 | 15,4 |
Working assets | 4,7 | 6,8 | 7,5 | 11 |
Other income costs | -∞ | |||
Depreciation | 0 | 0 | 0 | 93 |
% | % | % | p.p. | |
Profitability of capital | -133,6 | -101,4 | 54,8 | 156,2 |
Equity capital to total assets | -12,1 | -4,2 | -8,4 | -4,2 |
Gross profit margin | 2,9 | 0,9 | -0,9 | -1,8 |
EBITDA Margin | 3,5 | 1,7 | 0,1 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 37 | 44 | 36 | -8 |
Current financial liquidity indicator | 1.7881748676300049 | 1.746917963027954 | 1.9978523254394531 | 0,3 |
Net dept to EBITDA | 2.0676894187927246 | 4.777939796447754 | 101.1033706665039 | 96,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane